p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease

Published:2018-12 Issue: Volume:215 Page:64-72
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Yan Zhibin,Miao Xiaokang,Zhang Bangzhi,Xie Junqiu

Funder

National Natural Science Foundation of China

Ministry of Education

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference152 articles.

1. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005

2. AGA technical review on nonalcoholic fatty liver disease;Sanyal;Gastroenterology,2002

3. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis;Zhang;Proc. Natl. Acad. Sci. U. S. A.,2017

4. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management;McPherson;J. Hepatol.,2015

5. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study;Jang;Sci. Rep.,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD;Frontiers in Endocrinology;2023-12-19

2. Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †;International Journal of Molecular Sciences;2023-11-23

3. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets;Frontiers in Endocrinology;2023-06-08

4. BAG6 is a novel player in controlling nonalcoholic steatohepatitis: result from a comprehensivein-silicostudy;2023-05-07

5. Ameliorative effects of bilirubin on cell culture model of non-alcoholic fatty liver disease;Molecular Biology Reports;2023-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3